Lp(a) on GLP-1 agonists — anyone have experience?

CryptoCarl said:

Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 4.2% to 8.2% over 9 months. I supplemented with 2g EPA+DHA daily.

This matters because omega-3s are anti-inflammatory and cardioprotective, complementing the GLP-1 benefits. Target omega-3 index is >8%. Combined with the triglyceride reduction from the medication, my lipid profile is the best it's been in decades.

mike.trainer_LA said:

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 4.2% to 8.2% over 9 months.

Tracking labs for the lipid panel — here's the panel I get every 3 months and why:

• CMP: glucose, electrolytes, kidney function, liver enzymes
• Lipid panel: total cholesterol, LDL, HDL, triglycerides
• A1C: 3-month glucose average
• hsCRP: inflammatory marker
• CBC: blood counts, anemia screening
• B12, folate, iron: nutritional deficiency screening
• TSH, free T4: thyroid monitoring
• Lipase: pancreatic safety check

Total cost with insurance: about $37 copay. Without insurance, request cash-pay pricing from Quest/Labcorp — usually $162.

CryptoCarl said:

Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

Adding the clinical framing, because it changes how the question reads.

Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:

The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.